Becker's Healthcare August 20, 2024
Andrew Cass

Former R1 RCM CEO Joe Flanagan will return to the role after two private equity firms complete their acquisition of the revenue cycle management company.

TowerBrook Capital Partners and Clayton, Dubilier & Rice are acquiring R1 RCM in a deal valued at $8.9 billion that is expected to close by the end of the year, subject to stockholder and regulatory approvals. The firms made the decision to reappoint Mr. Flanagan after the closure of the deal, according to an Aug. 8 regulatory filing.

The filing includes an email to employees from current R1 RCM CEO Lee Rivas, who said he is “supportive of this move as R1 approaches its...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: RCM (Revenue Cycle Mgmt), Technology
Related Articles:
Aspirion lands 7th acquisition in 6 years
Revenue Cycle Risk Takers
Revenue Cycle AI Is Costly and Cumbersome. Here's Why Leaders Are Still Buying In.
Medical Tourism and Global Private Healthcare Drive Revenue Cycle Innovation: Black Book Report
4 Cornerstones for Successful AI Implementation in Hospital Revenue Cycle Management in 2025

Share This Article